Genknowme is a pioneering Swiss epigenetic company, transforming the way we measure the impact of the environment on health. With a specialized team and dedicated laboratory, we offer a patent-pending product, embraced by Switzerland's elite clinics. As part of our expansion, we're launching a groundbreaking product assessing chronic stress through epigenetics. Our mission transcends traditional preventive medicine, providing a comprehensive health analysis that sets new standards for understanding well-being and chronic disease prognosis. Join us in revolutionizing healthcare!
10.09.2025
New batch selected for the Kickstart accelerator (startupticker.ch)
13.02.2024
Third LeadiNNg to Scale-Up Cohort unveiled (startupticker.ch)
18.12.2023
Twenty-eight startups selected for the Innosuisse Scale up Coaching (startupticker.ch)
26.09.2023
Future of Health Grant kicks off with new cohort (startupticker.ch)
09.05.2023
Genknowme on the expansion course (startupticker.ch)
No milestones
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
The IMD Startup Competition provides an unique opportunity for regional technology startups to benefit from the help and insights of a team of dedicated, experienced IMD participants from the MBA and the Executive MBA programs.
Website:
www.genknowme.com
Headquarter:
Lausanne
Foundation Date:
January 2019
Technology:
Sectors: